Referral decisions based on a pre-hospital HEART score in suspected non-ST-elevation acute coronary syndrome: final results of the FamouS Triage study

Rudolf T Tolsma, Marion J Fokkert, Dominique N van Dongen, Erik A Badings, Aize van der Sluis, Robbert J Slingerland, Esther van 't Riet, Jan Paul Ottervanger, Arnoud W J van 't Hof, Rudolf T Tolsma, Marion J Fokkert, Dominique N van Dongen, Erik A Badings, Aize van der Sluis, Robbert J Slingerland, Esther van 't Riet, Jan Paul Ottervanger, Arnoud W J van 't Hof

Abstract

Aims: Although pre-hospital risk stratification of patients with suspected non-ST-elevation acute coronary syndrome (NSTE-ACS) by ambulance paramedics is feasible, it has not been investigated in daily practice whether referral decisions based on this risk stratification is safe and does not increase major adverse cardiac events (MACE). In Phase III of the FamouS Triage study, it was investigated whether referral decisions by ambulance paramedics based on a pre-hospital HEART score, is non-inferior to routine management.

Methods and results: FamouS Triage Phase III is a non-inferiority study, comparing the occurrence of MACE before (Phase II) and after (Phase III) implementation of referral decisions based on a pre-hospital HEART score. In Phase II, all patients were risk-stratified and referred to the hospital; in Phase III, low-risk patients (HEART score ≤ 3) were not referred. Primary endpoint was MACE (acute coronary syndrome, revascularization, or death) within 45 days. A total of 1236 patients were included. Mean age was 63 years, 43% were female, 700 patients were included in the second phase and 536 in the third phase in which 149 low-risk patients (28%) were not transferred to the hospital. Occurrence of 45 days MACE was 16.6% in Phase II and 15.7% in Phase III (P = 0.67). Percentage MACE in low-risk patients was 2.9% in Phase II and 1.3% in Phase III. After adjustments for differences in baseline variables, the hazard ratio of 45 days MACE in Phase III was 0.88 (95% confidence interval 0.63-1.25) as compared to Phase II.

Conclusion: Pre-hospital risk stratification of patients with suspected NSTE-ACS, avoiding hospitalization of a substantial number of low-risk patients, seems feasible and non-inferior to transferring all patients to the hospital.

Keywords: Acute-Coronary-Syndrome; HEART score; Triage; Pre-hospital.

© The Author(s) 2021. Published by Oxford University Press on behalf of the European Society of Cardiology.

Figures

Graphical abstract
Graphical abstract
Figure 1
Figure 1
Flow chart of patient inclusion in Phase III.

References

    1. Nawar EW, Niska RW, Xu J.. National Hospital Ambulatory Medical Care Survey: 2005 emergency department summary. Adv Data 2007;386:1–32.
    1. Poldervaart JM, Reitsma JB, Backus BE, Koffijberg H, Veldkamp RF, Ten Haaf ME, Appelman Y, Mannaerts HFJ, van Dantzig J-M, van den Heuvel M, El Farissi M, Rensing BJWM, Ernst NMSKJ, Dekker IMC, den Hartog FR, Oosterhof T, Lagerweij GR, Buijs EM, van Hessen MWJ, Landman MAJ, van Kimmenade RRJ, Cozijnsen L, Bucx JJJ, van Ofwegen-Hanekamp CEE, Cramer M-J, Six AJ, Doevendans PA, Hoes AW.. Effect of using the HEART score in patients with chest pain in the emergency department: a stepped-wedge, cluster randomized trial. Ann Intern Med 2017;166:689–697.
    1. Hyams JM, Streitz MJ, Oliver JJ, Wood RM, Maksimenko YM, Long B, Barnwell RM, April MD.. Impact of the HEART pathway on admission rates for emergency department patients with chest pain: an external clinical validation Study. J Emerg Med 2018;54:549–557.
    1. Cotterill PG, Deb P, Shrank WH, Pines JM.. Variation in chest pain emergency department admission rates and acute myocardial infarction and death within 30 days in the medicare population. Acad Emerg Med 2015;22:955–964.
    1. Foy AJ, Liu G, Davidson WR, Sciamanna C, Leslie DL.. Comparative effectiveness of diagnostic testing strategies in emergency department patients with chest pain: an analysis of downstream testing, interventions, and outcomes. JAMA Intern Med 2015;175:428–436.
    1. Safavi KC, Li S-X, Dharmarajan K, Venkatesh AK, Strait KM, Lin H, Lowe TJ, Fazel R, Nallamothu BK, Krumholz HM.. Hospital variation in the use of noninvasive cardiac imaging and its association with downstream testing, interventions, and outcomes. JAMA Intern Med 2014;174:546–553.
    1. Riley RF, Miller CD, Russell GB, Harper EN, Hiestand BC, Hoekstra JW, Lefebvre CW, Nicks BA, Cline DM, Askew KL, Mahler SA.. Cost analysis of the History, ECG, Age, Risk factors, and initial Troponin (HEART) Pathway randomized control trial. Am J Emerg Med 2017;35:77–81.
    1. Weinstock MB, Weingart S, Orth F, VanFossen D, Kaide C, Anderson J, Newman DH.. Risk for clinically relevant adverse cardiac events in patients with chest pain at hospital admission. JAMA Intern Med 2015;175:1207–1212.
    1. Rasmussen MB, Stengaard C, Sørensen JT, Riddervold IS, Hansen TM, Giebner M, Rasmussen C-H, Bøtker HE, Terkelsen CJ.. Predictive value of routine point-of-care cardiac troponin T measurement for prehospital diagnosis and risk-stratification in patients with suspected acute myocardial infarction. Eur Hear J Acute Cardiovasc Care 2019;8:299–308.
    1. Ishak M, Ali D, Fokkert MJ, Slingerland RJ, Tolsma RT, Badings E, van der Sluis A, van Eenennaam F, Mosterd A, Ten Berg JM, van 't Hof AW.. Fast assessment and management of chest pain patients without ST-elevation in the pre-hospital gateway (FamouS Triage): ruling out a myocardial infarction at home with the modified HEART score. Eur Hear J Acute Cardiovasc Care 2018;7:102–110.
    1. Stengaard C, Sørensen JT, Ladefoged SA, Lassen JF, Rasmussen MB, Pedersen CK, Ayer A, Bøtker HE, Terkelsen CJ, Thygesen K.. The potential of optimizing prehospital triage of patients with suspected acute myocardial infarction using high-sensitivity cardiac troponin T and copeptin. Biomarkers 2017;22:351–360.
    1. Sørensen JT, Terkelsen CJ, Steengaard C, Lassen JF, Trautner S, Christensen EF, Nielsen TT, Bøtker HE, Andersen HR, Thygesen K.. Prehospital troponin T testing in the diagnosis and triage of patients with suspected acute myocardial infarction. Am J Cardiol 2011;107:1436–1440.
    1. Tolsma RT, Van Dongen DN, Fokkert MJ, Ottervanger JP, Van Der Sluis A, Slingerland RJ, Van ’T, Hof AW.. 48 The pre-hospital HEART score is a strong predictor of MACE in patients with suspected non-STEMI. Eur Heart J 2017;38:ehx501.48.
    1. Stopyra JP, Harper WS, Higgins TJ, Prokesova JV, Winslow JE, Nelson RD, Alson RL, Davis CA, Russell GB, Miller CD, Mahler SA.. Prehospital modified HEART score predictive of 30-day adverse cardiac events. Prehosp Disaster Med 2018;33:58–62.
    1. Stengaard C, Sørensen JT, Ladefoged SA, Christensen EF, Lassen JF, Bøtker HE, Terkelsen CJ, Thygesen K.. Quantitative point-of-care troponin T measurement for diagnosis and prognosis in patients with a suspected acute myocardial infarction. Am J Cardiol 2013;112:1361–1366.
    1. Backus BE, Six AJ, Kelder JC, Bosschaert MAR, Mast EG, Mosterd A, Veldkamp RF, Wardeh AJ, Tio R, Braam R, Monnink SHJ, van Tooren R, Mast TP, van den Akker F, Cramer MJM, Poldervaart JM, Hoes AW, Doevendans PA.. A prospective validation of the HEART score for chest pain patients at the emergency department. Int J Cardiol 2013;168:2153–2158.
    1. van Dongen DN, Tolsma RT, Fokkert MJ, Badings EA, van der Sluis A, Slingerland RJ, van 't Hof AW, Ottervanger JP.. Pre-hospital risk assessment in suspected non-ST-elevation acute coronary syndrome: a prospective observational study. Eur Hear J Acute Cardiovasc Care 2020;9:5–12.
    1. van Dongen DN, Tolsma RT, Fokkert MJ, Badings EA, van der Sluis A, Slingerland RJ, van 't Hof AW, van 't Riet E, Ottervanger JP.. Referral decisions based on a prehospital HEART score in suspected non-ST-elevation acute coronary syndrome: design of the FamouS Triage 3 study. Future Cardiol 2020;16:217–226.
    1. Roffi M, Patrono C, Collet J-P, Mueller C, Valgimigli M, Andreotti F, Bax JJ, Borger MA, Brotons C, Chew DP, Gencer B, Hasenfuss G, Kjeldsen K, Lancellotti P, Landmesser U, Mehilli J, Mukherjee D, Storey RF, Windecker S; ESC Scientific Document Group. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 2016;37:267–315.
    1. Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, Caforio ALP, Crea F, Goudevenos JA, Halvorsen S, Hindricks G, Kastrati A, Lenzen MJ, Prescott E, Roffi M, Valgimigli M, Varenhorst C, Vranckx P, Widimský P; ESC Scientific Document Group. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2018;39:119–177.
    1. Amsterdam EA, Wenger NK, Brindis RG, Casey DE, Ganiats TG, Holmes DR, Jaffe AS, Jneid H, Kelly RF, Kontos MC, Levine GN, Liebson PR, Mukherjee D, Peterson ED, Sabatine MS, Smalling RW, Zieman SJ.. 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: executive summary. J Am Coll Cardiol 2014;64:2645–2687.
    1. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, Katus HA, Lindahl B, Morrow DA, Clemmensen PM, Johanson P, Hod H, Underwood R, Bax JJ, Bonow RO, Pinto F, Gibbons RJ, Fox KA, Atar D, Newby LK, Galvani M, Hamm CW, Uretsky BF, Steg PG, Wijns W, Bassand J-P, Menasché P, Ravkilde J, Ohman EM, Antman EM, Wallentin LC, Armstrong PW, Simoons ML, Januzzi JL, Nieminen MS, Gheorghiade M, Filippatos G, Luepker RV, Fortmann SP, Rosamond WD, Levy D, Wood D, Smith SC, Hu D, Lopez-Sendon J-L, Robertson RM, Weaver D, Tendera M, Bove AA, Parkhomenko AN, Vasilieva EJ, Mendis S; Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction. Third universal definition of myocardial infarction. Circulation 2012;126:2020–2035.
    1. Aujesky D, Roy P-M, Verschuren F, Righini M, Osterwalder J, Egloff M, Renaud B, Verhamme P, Stone RA, Legall C, Sanchez O, Pugh NA, N'gako A, Cornuz J, Hugli O, Beer H-J, Perrier A, Fine MJ, Yealy DM.. Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open-label, randomised, non-inferiority trial. Lancet 2011;378:41–48.
    1. Windecker S, Serruys PW, Wandel S, Buszman P, Trznadel S, Linke A, Lenk K, Ischinger T, Klauss V, Eberli F, Corti R, Wijns W, Morice M-C, di Mario C, Davies S, van Geuns R-J, Eerdmans P, van Es G-A, Meier B, Jüni P.. Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial. Lancet 2008;372:1163–1173.
    1. von Birgelen C, Sen H, Lam MK, Danse PW, Jessurun GAJ, Hautvast RWM, van Houwelingen GK, Schramm AR, Gin RMTJ, Louwerenburg JW, de Man FHAF, Stoel MG, Löwik MM, Linssen GCM, Saïd SAM, Nienhuis MB, Verhorst PMJ, Basalus MWZ, Doggen CJM, Tandjung K.. Third-generation zotarolimus-eluting and everolimus-eluting stents in all-comer patients requiring a percutaneous coronary intervention (DUTCH PEERS): a randomised, single-blind, multicentre, non-inferiority trial. Lancet 2014;383:413–423.
    1. Mabo P, Victor F, Bazin P, Ahres S, Babuty D, Da Costa A, Binet D, Daubert J-C.. A randomized trial of long-term remote monitoring of pacemaker recipients (The COMPAS trial). Eur Heart J 2012;33:1105–1111.
    1. García-Fernández FJ, Osca Asensi J, Romero R, Fernández Lozano I, Larrazabal JM, Martínez Ferrer J, Ortiz R, Pombo M, Tornés FJ, Moradi Kolbolandi M.. Safety and efficiency of a common and simplified protocol for pacemaker and defibrillator surveillance based on remote monitoring only: a long-term randomized trial (RM-ALONE). Eur Heart J 2019;40:1837–1846.
    1. Chow SC, Shao J, Wang H.. Sample Size Calculations in Clinical Research, 2nd ed. Florida: Chapman & Hall/CRC Boca Raton; 2008.
    1. Sealed Envelope Ltd. 2012. Power calculator for binary outcome non-inferiority trial. (10 October 2017).
    1. Backus BE, Tolsma RT, Boogers MJ.. The new era of chest pain evaluation in the Netherlands. Eur J Emerg Med 2020;27:243–244.
    1. Stopyra JP, Snavely AC, Smith LM, Harris RD, Nelson RD, Winslow JE, Alson RL, Pomper GJ, Riley RF, Ashburn NP, Hendley NW, Gaddy J, Woodrum T, Fornage L, Conner D, Alvarez M, Pflum A, Koehler LE, Miller CD, Mahler SA.. Prehospital use of a modified HEART Pathway and point-of-care troponin to predict cardiovascular events. PLoS One 2020;15:e0239460.
    1. McConaghy JR, Sharma M, Patel H.. Acute chest pain in adults: outpatient evaluation. Am Fam Physician 2020;102:721–727.
    1. Backus BE, ter Avest E, Gerretsen BM, Viljac A, Tolsma RT.. Organization of prehospital care in the Netherlands:a perspective article. Eur J Emerg Med 2020;27:398–399.
    1. Six AJ, Cullen L, Backus BE, Greenslade J, Parsonage W, Aldous S, Doevendans PA, Than M.. The HEART score for the assessment of patients with chest pain in the emergency department. Crit Pathw Cardiol 2013;12:121–126.
    1. van Dongen DN, Fokkert MJ, Tolsma RT, van der Sluis A, Slingerland RJ, Badings EA, van 't Hof AWJ, Ottervanger JP.. Accuracy of pre-hospital HEART score risk classification using point of care versus high sensitive troponin in suspected NSTE-ACS. Am J Emerg Med 2020;38:1616–1620.
    1. Wassie M, Lee M-S, Sun BC, Wu Y-L, Baecker AS, Redberg RF, Ferencik M, Shen E, Musigdilok V, Sharp AL.. Single vs serial measurements of cardiac troponin level in the evaluation of patients in the emergency department with suspected acute myocardial infarction. JAMA Netw Open 2021;4:e2037930.
    1. de Meijer C, Wouterse B, Polder J, Koopmanschap M.. The effect of population aging on health expenditure growth: a critical review. Eur J Ageing 2013;10:353–361.
    1. Bodenheimer T. High and rising health care costs. Part 1: seeking an explanation. Ann Intern Med 2005;142:847–854.
    1. Hartwig J. What drives health care expenditure?–Baumol’s model of ‘unbalanced growth’ revisited. J Health Econ 2008;27:603–623.

Source: PubMed

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas

3
Se inscrever